Ultrapar Participações S.A (UGPA3) Fair Value & Analysis
Energy · BR · Market cap R$26.7B
Analysis
Ultrapar Participações S.A (UGPA3) currently trades at R$25.49, while our model-based Fair Value estimate is R$32.14 — implying the stock looks roughly 26.1% undervalued today. We read business quality at 89/100 (high quality), in the Energy sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Ultrapar Participações S.A., through its subsidiaries, operates in the energy, mobility, and logistics infrastructure sectors in Brazil, the rest of Europe, the United States, Canada, other Latin American countries, Oceania, and internationally. It operates through Ultragaz, Ipiranga, Ultracargo, and Hidrovias segments. The company distributes and sells oil-related products, biofuels, gasoline, ethanol, diesel, fuel oil, kerosene, natural gas for vehicles, and additive fuels under the Ipimax brand to carriers, resellers, and retailers; operates service stations under the Ipiranga brand and convenience stores under the AmPm brand; and produces and sells lubricants under the ICONIC brand. It also engages in the distribution of bulk and bottled liquefied petroleum gas for the residential, condominium, trade, services, industrial, and agribusiness sectors; operation of a natural gas pipeline network; and provision of renewable electricity for businesses and households, as well as compre…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.